We are live on ! Find out more
MACM

March Altus Capital Management Portfolio holdings

AUM $16M
1-Year Est. Return 18.92%
This Fund
S&P 500
This Quarter Est. Return
+15.65%
1 Year Est. Return
+18.92%
3 Year Est. Return
+155.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16M
AUM Growth
+$3.05M
Cap. Flow
+$1.62M
Cap. Flow %
10.11%
Top 10 Hldgs %
98.74%
Holding
12
New
4
Increased
2
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$1.81M
2
TSRO
TESARO, Inc.
TSRO
+$934K
3
ZTS icon
Zoetis
ZTS
+$805K
4
BIIB icon
Biogen
BIIB
+$770K
5
DXCM icon
DexCom
DXCM
+$223K

Top Sells

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$1.4M
2
LLY icon
Eli Lilly
LLY
+$1.08M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$339K
4
ALXN
Alexion Pharmaceuticals
ALXN
+$309K

Sector Composition

Rank Sector Weight
1 Healthcare 87.21%

No holdings matched the selected filter criteria.

Similar funds

IC
IKOS CIF Limassol, Cyprus $16.7M AUM 0.4% 1-Year Est. Return
PA
Para Advisors New York $17.5M AUM 3.99% 1-Year Est. Return
GMIM
General Motors Investment Management New York $20.3M AUM 55.51% 1-Year Est. Return
JHWCP
J.H. Whitney Capital Partners New Canaan, Connecticut $11.5M AUM 86.36% 1-Year Est. Return
SMPIAI
Spark Management Partners III (AIV I) Boston, Massachusetts $10.1M AUM 12.29% 1-Year Est. Return
NCMG
NCM Capital Management Group Durham, North Carolina $8.24M AUM 11.99% 1-Year Est. Return
CAD
Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return
GPI
Georgian Partners I Toronto, Ontario, Canada $25.3M AUM 21.88% 1-Year Est. Return

March Altus Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, March Altus Capital Management held 12 positions worth $16M, up 24% from $12.9M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

March Altus Capital Management deployed $1.62M of net new capital in Q3 2016, opening 4 new positions and adding to 2 existing holdings. Its largest new stake was TESARO, Inc.: 10,000 shares worth $1M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 89% a quarter earlier.

On the sell side, the largest reduction was Eli Lilly, an estimated $1.08M trimmed.

  • March Altus Capital Management's largest Q3 2016 buy was TESARO, Inc.: 10,000 shares worth $1M.
  • March Altus Capital Management added most to Edwards Lifesciences in Q3 2016, an estimated $1.81M increase.
  • March Altus Capital Management's biggest Q3 2016 reduction was Eli Lilly, cutting an estimated $1.08M.
  • March Altus Capital Management fully exited Align Technology in Q3 2016, selling an estimated $1.4M.
  • March Altus Capital Management's ten largest holdings make up 99% of its $16M portfolio in Q3 2016.
  • March Altus Capital Management opened 4 new positions and closed 1 in Q3 2016.
  • March Altus Capital Management's portfolio value rose 24% quarter-over-quarter to $16M.

Based on March Altus Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.